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In single mouse macrophages stimulated by platelet-activating factor (PAF), the intracellular calcium concentration (Cai) 
monitored with fura-2 at room temperature presents a biphasic increase, including a transient and a more sustained com- 
ponent. After pulse administration f PAF, the first phase lasts for a few seconds and reaches a peak value of 0.5-1 
/~M Ca z+ at high PAF concentration. The amplitude of this peak is independent of extracellular Ca z÷ concentration, 
suggesting that the initial Ca 2÷ transient isdue to the release of Ca 2÷ from intracellular stores. The second phase of the 
response lasts for several minutes; its maximum amplitude is reached 1-2 min after the brief initial PAF stimulation. 
This phase, suppressed in zero external Ca 2÷ and increased in 10 mM Ca z+, is probably due to influx of Ca 2÷ through 
the plasma membrane. This secondary Ca 2÷ increase is blocked by 10-50/tM lanthanum. At low PAF concentration, 
the initial Ca z+ transient is not followed by a second phase, showing that the initial rises of Ca 2÷ and of its activator 
(presumably inositol trisphosphate) are not sufficient to trigger the second phase of Ca 2÷ increase. 
Ca2+; Fura-2; Macrophage; Platelet-activating factor 
1. INTRODUCTION 
Platelet-act ivat ing factor (PAF) ,  1-O-alkyl-2- 
acetyl -sn-glyceryl -3-phosphorylchol ine,  is a phos- 
phol ip id  secreted by various cell types including 
platelets, macrophages,  mastocytes and endothe- 
l ial cells (review [1]). Specific receptors for PAF  
have been described on platelets [2], po lymorpho-  
nuclear lymphocytes [3] and some smooth muscles 
[4]. PAF  exerts a variety o f  biological  effects, such 
as platelet aggregation,  contract ion o f  smooth 
muscle, increased vascular permeabi l i ty  and 
release of  histamine f rom mast cells (review [1]). 
When appl ied to macrophages,  PAF  st imulates the 
oxidat ive burst,  release of  arachidonic acid and 
some of  its metabol i tes (prostaglandin E and 
thromboxane B2), and cell spreading [5,6]. The 
mode of  act ion of  PAF  is far f rom being under- 
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stood.  In platelets and neutrophi ls ,  PAF  activates 
the phosphol ipase C-mediated hydrolysis of  poly- 
phosphoinos i t ides [7]. In platelets and macro-  
phages, PAF  induces an increase in intracel lular 
Ca 2+ concentrat ion (Cai), this increase results 
part ly  f rom the release o f  Ca 2+ from intracel lular 
stores, and part ly  f rom inf lux of  Ca 2+ from the 
extracel lular solut ion [8]. The latter results were 
obta ined with the quin-2 method [9]. The average 
signal obtained on a large number o f  cells was not 
suitable for a thorough analysis of  the contr ibu-  
t ions of  the two components  to the PAF- induced 
Ca 2+ rise. 
Here,  we have measured Cai with the f luorescent 
dye fura-2 [10] on single cells. With  a double per- 
fusion system, PAF  could be appl ied to cells for 
var ious periods (as short as 2 s) and immediately 
washed, and the extracel lular Ca 2+ concentrat ion 
could be changed in less than 200 ms. The resulting 
t ime resolut ion al lowed us to separate clearly the 
two phases of  the Ca 2+ rise elicited by PAF ,  and 
to analyze quantitat ively their kinetic characteris-  
tics and dependence upon PAF  concentrat ion.  
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2. MATERIALS AND METHODS 
Mouse peritoneal macrophages were collected and cultured as 
described [11]. Experiments were performed at room temper- 
ature 5-25 days after plating the cells. 
2.1. Solutions 
Bath solution contained (in mM) 5 KC1, 140 NaCl, 1 Cat12, 
1 MgC12 (pH 7.2) fixed with 5 Hepes-Na. Some experiments 
were in high Ca z+ (4 or 9 mM Ca 2+ added to the normal solu- 
tion) or Ca2+-free solutions (0.5 mM EGTA, 0 Ca2+). PAF 
(Sigma) was dissolved in ethanol at 40/~g/ml and stored at 
- 20°C. Diltiazem and ( + )-tubocurarine were from Sigma, and 
QX 222 from Astra Pharmaceutical Products. 
2.2. Perfusion systems 
PAF was applied with a pipette (opening -20/~m) rapidly 
brought close to the cell with a hydraulic micromanipulator, 
under red light. Solution changes taking place in less than 1 s 
could be achieved in this way. In addition, we used a fast perfu- 
sion system based on a U-tube [10], with which changes in bath 
solution could be effected in less than 200 ms. Whena test solu- 
tion was not flowing out of the U-tube, bath solution was con- 
tinuously sucked through the same opening, contributing to the 
fast termination of PAF application by the leaking pipette. 
During prolonged PAF application, this aspiration avoided 
flooding of the rest of the dish with PAF and desensitization f
other cells. 
2.3. Calcium measurements 
Measurements of intracellular calcium concentration on 
single cells with the Ca 2+ indicator fura-2 were made as follows. 
Cells were incubated for 30 min at 37°C with 2/~M fura-2 
acetoxy methyl ester plus 0.4 mg/ml  Pluronic (Molecular 
Probes). Generally, this procedure resulted in a fura-2 loading 
which yielded homogeneous fluorescence within each cell. In a 
few preparations, brilliant intracellular granules were observed. 
These could be due to the endocytosis of fura-2, followed by its 
concentration i lysosomes [12] or to intracellular transport of  
the dye into cytoplasmic vacuoles [13]. Such cells had an ap- 
parent level of resting Ca 2+ which was abnormally low and 
responded poorly to PAF stimulation. These preparations were 
discarded in the present study. Measurements of Cai were per- 
formed as in [14] (except hat the photodiode was replaced by 
a Hamamatsu 647-01 photomultiplier). 
3. RESULTS 
3.1. Relation between PAF  concentration and 
characteristics o f  the Ca~ + response 
The resting level of Cai was usually around 
100 nM except during the first 2-3 days after 
plating (200-400 nM). ,Application of 4 ng/ml 
PAF to these cells for a few seconds elicited, after 
some delay (see below), an increase in Cai compos- 
ed of two phases, as shown in fig. lb: a transient in- 
crease (phase I) followed by a second period (phase 
II) where, for a few minutes, Cai remained higher 
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Fig.l .  Typical changes in Cai induced by PAF applications of 
various concentrations. In this and subsequent figures the 
duration of PAF application is indicated by the bar above each 
record. 
than the resting level. The changes in Cai induced 
by 40 ng/ml PAF (fig.la) were similar to those 
elicited by 4 ng/ml PAF (fig.lb), except hat the 
delay was reduced and barely measurable (< 1 s). 
PAF concentrations lower than 4 ng/ml induced 
Ca 2+ changes (fig. lc,d) which differed from those 
induced by higher doses in several respects: (i) the 
initial delay was increased; (ii) the amplitude of the 
initial Ca 2+ peak was slightly reduced; (iii) the 
magnitude of the second phase was reduced to a 
greater extent vs the first phase; (iv) with PAF at 
0.04-0.004 ng/ml, only a fraction of the cells gave 
a response. 
Fig.2a shows the curves relating the amplitude 
of the initial Ca 2+ transient to PAF concentration. 
The upper curve was obtained by recording only 
those peaks which were different from zero, 
whereas the overall mean, including the failures to 
respond to PAF, is shown in the lower trace. In the 
upper curve, it appears that at a PAF concentra- 
tion 1000-times maller than that necessary for 
maximum response, when phase I is triggered, the 
response is still half of the maximum. The ECs0 
which can be derived from the lower curve is 
around 0.2 ng/ml, i.e. 0.4 nM PAF. The curve 
relating the duration of the initial delay to the 
reciprocal of the PAF concentration is shown in 
fig.2b. It shows an initial part which is linear. At 
very low PAF concentrations, the curve tends 
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Fig.2. Effect of PAF concentration  the initial peak amplitude (a) and the preceding delay (b). (a) On the abscissa, a logarithmic 
scale was used because of the wide range of PAF concentrations explored (between 4 x 10 -~3 and 4 x 10 -s g/ml). Squares correspond 
to the average of the amplitude of the peaks of responding ceils and circles ( + SD) to the overall average, including the failures. The 
dotted line indicates the Cai level in the absence of PAF stimulation. (b) Average delays (+ SD) preceding a response as a function 
of reciprocal PAF concentration. Dotted line: maximum average delay observed at low PAF concentration. All curves were drawn 
by eye. Averages _+ SD determined on 5-9 experimental values in a and b. 
towards a limit, which corresponds to the max- 
imum delay that can precede a rise of Ca2+: on 
average, 27 _+ 12 s (mean + SD, n = 7) for PAF 
concentrations ranging between 0.04 and 
0.004 ng/ml. 
3.2. Effects of extracellular Ca 2+ concentration 
We next examined the influence of extracellular 
Ca 2+ (Cao) on the properties of the two phases of 
the Ca 2+ rise elicited by 4 ng/ml PAF. The ampli- 
tude of the initial Ca 2÷ peak was scarcely affected 
by changes in Ca,,: PAF  stimulation performed in 
a Ca2+-free solution gave Ca z+ transients of nor- 
mal amplitude. Increasing Ca,, from 1 to 10 mM 
did not modify significantly the amplitude of the 
initial peak. 
In contrast, the amplitude of phase II was 
strongly dependent upon Cao being markedly 
enhanced in 10 mM Cao. The ratio of the ampli- 
tudes of phase II/phase I was 0.24 + 0.36 (mean + 
SD, n = 8) in 1 mM Cao and 0.91 + 0.46 (n = 6) 
in 10 mM Cao. The two values are significantly dif- 
ferent (t-test, p < 0.01). 
Fig.3c shows the increase in Cai elicited by PAF 
in the absence of external Ca 2+. The cell was bath- 
ed in 1 mM Ca 2+, but PAF was applied for a few 
seconds in a Ca2+-free solution, and another 
Ca2+-free solution was applied by U-tube perfu- 
sion (see section 2) immediately after PAF stimula- 
tion. Under these conditions, only a transient rise 
in Ca 2+ was obtained, and Cai returned to its 
resting level after 1 min. Upon readmission of 
1 mM Ca 2÷ to the bath, Cai rose to several hun- 
dred nanomolar. For several minutes after PAF 
stimulation, the level of Cai could be varied by 
changing Cao. Similar changes of Cao before PAF 
stimulation had no effect on Cai (not shown). 
These data suggest hat phase I, which is some- 
times well separated from phase II (figs la,3a), and 
sometimes less so (fig.lb), does not depend upon 
Ca,, and therefore probably results from a Ca 2÷ 
release from intracellular stores. On the other 
hand, the amplitude of phase II is increased in high 
Cao, and  suppressed in Ca 2÷ free solutions, and 
thus probably arises from influx of Ca 2+ through 
the plasma membrane. 
These conclusions are confirmed by the experi- 
ment shown in fig.3d: this cell had been kept for 
more than 1 h in a Ca2+-free solution. Never- 
theless, a transient Ca 2÷ response could be evoked 
by PAF under these conditions (in the experiment 
of fig.3d, the amplitude of the Ca 2÷ transient is 
small, but not significantly different from that ob- 
tained on the same day with 1 mM Cao). Changes 
of Cao from 0 to 10 mM for brief periods induced 
an increase in Cal after PAF stimulation, but not 
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Fig.3. Cai variations induced in different cells by brief applications of PAF (4 ng/ml). Applications of PAF by the leaking pipette 
are indicated by thick bars and of various solutions by U-tube perfusion by thin bars. (a) Example of a response with a large initial 
peak and long duration (Cao = 5 mM). (b) Reduction of Cai during phase II induced by application of 50/~M lanthanum (Cao = 
1 mM). (c) Reduction of Cal during phase II, induced by application of a Ca2÷-free solution (0.5 mM EGTA). Control Cao = 1 mM. 
PAF was diluted in the Ca2÷-free solution. (d) Ca 2÷ response to PAF in a cell bathed in Ca2÷-free solution (0.5 mM EGTA). Effect 
of brief applications of 10 mM Cai, before and after PAF stimulation. 
before. Note that in this example, the maximum 
amplitude of phase II is reached several minutes 
after the brief stimulation by PAF. 
The influx of Ca 2÷ giving rise to phase II is likely 
to be due to the opening of ionic channels. We 
have tried several substances which have been 
shown to block either Ca 2÷ channels or cationic 
channels. Three of them did not affect the second 
phase of the Ca 2÷ response to PAF, namely 
diltiazem (200/zM), (+)-tubocurarine (100/~M) 
and QX 222 (100/~M). When the trivalent lan- 
thanum cation La 3÷ (10-50/~M) was applied dur- 
ing phase II, the level of Cai was rapidly reduced, 
as would be expected if La 3÷ efficiently blocked 
Ca 2÷ influx (fig.3b). This effect was immediately 
reversible upon washing La 3÷. 
3.3. Kinetics of PAF response 
The initial rise of Cai during a response to PAF 
developed in less than 1 s. This cannot be shown 
with a good time resolution by measuring the ab- 
solute value of Cai, at a rate limited by that of the 
rotating filter ( -5  Hz). For this experiment fura-2 
was excited at a single wavelength (385 nm) and its 
fluorescence sampled at 100 Hz. It is reasonable to 
assume that the time courses of the PAF-induced 
fluorescence decrease and Cai increase are iden- 
tical. Note that in this example (fig.4a), the sharp 
increase in Cai (indicated by the decrease in 
fluorescent signal) was preceded by a slower and 
smaller Ca 2÷ increase. This initial creep was not 
always so obvious. In this example, the change in 
fluorescence from 20 to 80°7o f the full amplitude 
took 200 ms, not much longer than the time re- 
quired for the solution change. This rate of rise of 
Cai is similar to that observed after stimulation of 
muscarinic receptors in exocrine glands [15,16]. 
The rate of decay of phase I was better observed 
in Ca2+-free solutions, in order to separate it from 
the second phase. In several instances (not shown), 
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Fig.4. Kinetics of PAF-induced Cai changes. (a) Fluorescence measured after excitation at 385 nm. Fluorescence d crease corresponds 
to Cat increase induced by PAF (phase I). (b) The decay of the Cat peak induced by PAF in Ca2+-free solution can be fitted by the 
sum of two exponentials (time constants 5.7 and 26 s). Here and in d, dots correspond to experimental points and the continuous line 
to the exponential fit. (c) Example of a Cat decrease induced by switching Cao from 1 to 0 Ca 2+ during phase II, fitted by an exponential 
(time constant 10 s). (d) Time constant of decay of Cal in experiments of the type shown in (c), as a function of the plateau value 
of Cal before switching to 0 Ca 2+. 
after a Ca 2+ transient induced by PAF  in a 
Ca2+-free solution, Cat returned to a lower level 
than before PAF  stimulation, suggesting that 
during phase I, activation of  the Ca 2+ pumps out- 
lasts the Ca 2+ transient. This decay was generally 
biphasic, and could be fitted by the sum of  two ex- 
ponentials (fig.4b). Our interpretation is that the 
initial fast decrease of  Cat could be due to the ac- 
tivity o f  two pumps (plasmalemmal and of  in- 
tracellular stores). After these stores have been 
filled, Ca 2+ extrusion would depend only on the 
plasmalemmal Ca 2+ pump, and Cat would de- 
crease more slowly. 
During phase II, an apparent rate of  Ca 2+ influx 
can be estimated by measuring the rate of  Cat in- 
crease induced by switching the extracellular solu- 
t ion f rom 0 to 1 or 10 mM Ca 2+. The half rise 
times of  these increases averaged 3.1 _+ 2.2 s 
(mean _+ SD, n = 16). This Ca 2+ rise is thus much 
slower than during phase I. 
When a Ca2+-free solution was rapidly applied 
to the cell during phase II, Cat slowly returned to 
resting levels, generally with an exponential time 
course, as shown in fig.4c. The time constant of  
decay of  Cat (1") depended upon the Cat value at- 
tained during phase II, r being smaller for higher 
plateau values of  Cat. This is illustrated in fig.4d, 
which gives the relation between 1" and the Cat 
value measured before the application of  the 
Ca2+-free solution. Assuming that in phase II in- 
tracellular stores are refilled, the decrease in Ca[ 
would be due to the activity o f  the plasmalemmal 
203 
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pump, extruding Ca 2÷ after dissociation from 
Ca2+-binding proteins. The accelerated return of 
Cai to basal levels when the initial Ca 2+ value is 
high probably reflects the Ca 2÷ dependence of this 
pump. 
4. DISCUSSION 
In a variety of cells, the activation of some mem- 
brane receptors triggers an increase in Cai due 
partly to the release of Ca 2÷ from intracellular 
stores and partly to influx of Ca 2÷ through the 
plasma membrane. Such increases follow, for in- 
stance, the activation of muscarinic receptors in 
exocrine glands [17], substance P receptors in mast 
cells [18], purinergic receptors in endothelial cells 
[19], PAF receptors or ATP receptors in macro- 
phages [8,20] or are triggered by the cross-linking 
of surface immunoglobulins in B cells [21]. 
Several conditions must be met in order to 
analyze such responses: (i) Since the response 
presents a fast component which is not synchro- 
nous in all the cells of a population, Ca 2÷ measure- 
ments should not be performed on a large number 
of cells, but on single cells. (ii) During prolonged 
stimulation, the second phase could be contamin- 
ated by a small but sustained release of Ca 2÷ from 
intracellular stores. Thus, the separation of the 
two phases should be drawn out by triggering the 
response via brief administration of the stimul- 
ating molecule. (iii) Fast changes of the extra- 
cellular solution are necessary for the kinetic 
analysis of Ca 2÷ changes during the two phases of 
the response. (iv) The amplitude of each phase 
should be sufficiently large. 
Here, a quantitative analysis of the two phases 
of the Ca 2÷ rise elicited by PAF in macrophages 
could be performed because all these conditions 
were fulfilled. 
4.1. Dose-response curve: amplitude and delay 
The dose-response curve that we have establish- 
ed relates the amplitude of the peak of the first 
phase of the Ca 2+ response to PAF concentration. 
The ECso derived from such a functional dose- 
response curve (0.4 nM) is comparable to the Ko 
previously reported: 0.6 nM in neutrophils [22], 
0.1 nM in polymorphonuclear leucocytes [3]. One 
peculiarity of this curve is that it spreads over 
several orders of magnitude of PAF concentration. 
A double-reciprocal plot of the data gives a rela- 
tion which is less than linear. This apparent 
negative cooperativity could mean that the PAF- 
receptor stoichiometry is less than unity; one PAF 
molecule would then activate several receptors. 
Alternatively, several kinds of receptors could be 
involved in the PAF response. 
However, there are two features of these 
responses which are not taken into account in this 
curve. The first is that, at low PAF concentration, 
the apparent low amplitude of the response is the 
average of a majority of complete failures to res- 
pond, and of a minority of responses of almost 
normal amplitude. At a PAF concentration where 
more than 60°70 of the cells failed to respond, the 
amplitude of the Ca 2+ peak of the responding cells 
was still ~50o70 of the maximum. Such behaviour 
may reveal the existence of a threshold and of 
positive feed-back: if Cai reaches a certain level, 
then it increases very rapidly above this level [23]. 
A second feature of the Ca 2+ response is the ex- 
istence of a delay between PAF application and 
Ca 2+ rise. A similar delay was observed after 
stimulation of various receptors in platelets [24] 
and of muscarinic receptors in exocrine glands; in 
these glands, with supra-maximal gonist concen- 
tration, a minimum delay of 70-700 ms was 
observed [15,16]. At high PAF concentrations, the 
delay preceding the response is linearly related to 
the reciprocal of the PAF concentration. A similar 
situation was described for the muscarinic 
response (to moderate and high doses of acetyl- 
choline) in lacrimal glands [15]. The authors con- 
clude that this delay should represent he time 
needed to build up the concentration of an in- 
tracellular component, X, directly involved in the 
response. We have observed that at very low PAF 
concentrations, when a response is obtained, the 
preceding delay is never longer than 30 s on the 
average. We suggest hat this limiting delay could 
be the time at which the concentration of X passes 
through a maximum (after which it is degraded or 
diluted). Our data indicate that the time at which 
this maximum is reached should be independent of
PAF concentration. At high PAF concentration, X 
reaches a threshold value well before this time. At 
lower PAF concentrations the most likely time 
where the threshold can be reached is at the X 
peak. 
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4.2. Relative importance of the two phases of the 
Ca e+ response 
It has been claimed that after PAF stimulation 
the Cai increase due to Cai release from intracel- 
lular stores was much smaller than the Ca 2+ influx 
[8]. In contrast, it appears in our data that the rate 
of Ca 2+ entry in the cytoplasm is much larger when 
Ca 2+ is released from intracellular stores than 
when it comes from the extracellular solution. As 
a result the Ca 2+ concentration reached during 
phase I is greater than during phase II. This is true 
for pulse administrations of PAF as well as for 
prolonged PAF applications (not shown). There 
are two reasons why in previous estimates, the 
relative importance of Ca 2+ release was underes- 
timated. Firstly, in a cell population, PAF-induced 
Ca 2+ transients are not necessarily synchronous in
all the cells. As a consequence, the average peak is 
smaller than the individual peaks. Secondly, 
quin-2 measurements are generally carried out with 
a high intracellular concentration of dye (around 
1 mM), which exerts a Ca2+-buffering effect par- 
ticularly marked on Ca 2+ transients (see e.g. [18]). 
One can predict hat biological processes with dif- 
ferent Ca 2+ requirements are regulated during 
phase I (large and brief Ca 2+ rise) and during phase 
II (lower but prolonged increase in Cai). 
4.3. Control of the second phase of the PAF 
response 
In macrophages, Ca 2+ influx during this phase is 
not due to the modulation of voltage-dependent 
Ca 2+ channels which occurs in other cells (review 
[25]), since macrophages are devoid of such chan- 
nels [11,26]. Rather, this influx is probably due to 
the opening of receptor-operated Ca2+-channels. 
Such channels have been described in neutrophils 
[27], T lymphocytes [28], mast cells [18] and 
platelets [29]. They can be blocked by nickel or 
cadmium [28,29]. Since these channels could have 
a cationic selectivity, we have tried various 
blockers known to affect the cationic channel of 
the nicotinic receptor (QX222, (+)-tubocurarine; 
review [30]) or that of photoreceptors (diltiazem, 
see [31]). None of these blockers affected Ca 2+ in- 
flux in macrophages. It would be of major impor- 
tance to find a blocker of these channels more 
specific than the only one that was efficient here, 
lanthanum. 
It has been suggested that these receptor- 
operated Ca 2+ channels could be opened either by 
intracellular Ca 2+ [27], or by IP~ [18,32]. Our data 
do not support hese hypotheses. The fact that at 
low PAF concentration, the initial Ca 2+ (and 
presumably IP3) peak is not followed by Ca 2+ in- 
flux indicates that the initial increases in Ca 2+ and 
IP3 are not sufficient o activate receptor-operated 
Ca 2+ channels. In addition, the peak of the second 
phase is reached between 1 min and several 
minutes after the Ca 2+ (and presumably the IP3) 
peaks have taken place. The final reason against 
the Ca 2+ hypothesis being valid can be drawn from 
the observation that if a Ca2+-free solution is ap- 
plied to a cell during phase II for a duration suffi- 
cient to lower Cai to resting levels, upon 
readmission of external Ca 2+, Cai increases 
without delay. Therefore, the membrane channels 
responsible for phase II, once activated, may re- 
main open even when Cai is low. Recent results ob- 
tained with various growth factors on 3T3 cells 
also argue in favour of a dissociation between 
hydrolysis of polyphosphoinositides and Ca 2+ in- 
flux [33]. A similar conclusion can also be drawn 
from the observation that in salivary cells, a low 
dose of phorbol esters can block the Ca 2+ release 
elicited by carbachol, without blocking the car- 
bachol-induced Ca 2+ influx [34]. 
Future work will be necessary in order to deter- 
mine whether direct activation by G-proteins, or 
phosphorylation, or other mechanisms, are in- 
volved in the control of receptor-operated Ca2+ 
channels. The PAF-macrophage system, where a 
secondary Ca 2+ rise of large amplitude clearly 
distinct from the initial Ca 2+ transient can be 
observed, should prove useful in elucidating this 
problem. 
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